TMPRSS4 induces cancer cell invasion through pro-uPA processing.

[1]  Semi Kim,et al.  TMPRSS4 upregulates uPA gene expression through JNK signaling activation to induce cancer cell invasion. , 2014, Cellular signalling.

[2]  Semi Kim,et al.  Discovery of novel 2-hydroxydiarylamide derivatives as TMPRSS4 inhibitors. , 2013, Bioorganic & medicinal chemistry letters.

[3]  M. Pajares,et al.  Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology , 2011, British Journal of Cancer.

[4]  W. Jiang,et al.  Type II transmembrane serine protease (TTSP) deregulation in cancer. , 2011, Frontiers in bioscience.

[5]  J. Hooper,et al.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment. , 2010, The Biochemical journal.

[6]  Semi Kim,et al.  TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways. , 2010, Carcinogenesis.

[7]  C. Marshall,et al.  Regulation of cell signalling by uPAR , 2010, Nature Reviews Molecular Cell Biology.

[8]  T. Bugge,et al.  Type II transmembrane serine proteases in development and disease. , 2008, The international journal of biochemistry & cell biology.

[9]  K P Lee,et al.  TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial–mesenchymal transition , 2008, Oncogene.

[10]  M. Crippa.  Urokinase-type plasminogen activator. , 2007, The international journal of biochemistry & cell biology.

[11]  R. Vij,et al.  Pro-urokinase-type Plasminogen Activator Is a Substrate for Hepsin* , 2006, Journal of Biological Chemistry.

[12]  B. Rossier,et al.  Activation of epithelial sodium channels by mouse channel activating proteases (mCAP) expressed in Xenopus oocytes requires catalytic activity of mCAP3 and mCAP2 but not mCAP1. , 2006, Journal of the American Society of Nephrology : JASN.

[13]  J. Quigley,et al.  Matrix metalloproteinases and tumor metastasis , 2006, Cancer and Metastasis Reviews.

[14]  Q. Duh,et al.  ECM1 and TMPRSS4 Are Diagnostic Markers of Malignant Thyroid Neoplasms and Improve the Accuracy of Fine Needle Aspiration Biopsy , 2005, Annals of surgery.

[15]  L. Lund,et al.  Plasminogen activation and cancer , 2005, Thrombosis and Haemostasis.

[16]  Chen-Yong Lin,et al.  Inhibition of Tumor Invasion by Genomic Down-regulation of Matriptase through Suppression of Activation of Receptor-bound Pro-urokinase* , 2004, Journal of Biological Chemistry.

[17]  James P. Quigley,et al.  Membrane anchored serine proteases: A rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer , 2003, Cancer and Metastasis Reviews.

[18]  L. Magnelli,et al.  Multiple pathways of cell invasion are regulated by multiple families of serine proteases , 2004, Clinical & Experimental Metastasis.

[19]  R. Dickson,et al.  Type II transmembrane serine proteases , 2003, Thrombosis and Haemostasis.

[20]  F. Blasi,et al.  Binding of Sp1 to the proximal promoter links constitutive expression of the human uPA gene and invasive potential of PC3 cells. , 2002, Blood.

[21]  M. Duffy.  Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers. , 2001, Biochemical Society transactions.

[22]  W. Stetler-Stevenson,et al.  Proteases in invasion: matrix metalloproteinases. , 2001, Seminars in cancer biology.

[23]  J. Clements,et al.  Type II Transmembrane Serine Proteases , 2001, The Journal of Biological Chemistry.

[24]  R. Dickson,et al.  Activation of Hepatocyte Growth Factor and Urokinase/Plasminogen Activator by Matriptase, an Epithelial Membrane Serine Protease* , 2000, The Journal of Biological Chemistry.

[25]  Jennifer L. Harris,et al.  Cellular Localization of Membrane-type Serine Protease 1 and Identification of Protease-activated Receptor-2 and Single-chain Urokinase-type Plasminogen Activator as Substrates* , 2000, The Journal of Biological Chemistry.

[26]  T. Gress,et al.  A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. , 2000, Cancer research.

[27]  P. Verde,et al.  Role of Distinct Mitogen-Activated Protein Kinase Pathways and Cooperation between Ets-2, ATF-2, and Jun Family Members in Human Urokinase-Type Plasminogen Activator Gene Induction by Interleukin-1 and Tetradecanoyl Phorbol Acetate , 1999, Molecular and Cellular Biology.

[28]  M. Duffy,et al.  The urokinase‐type plasminogen activator system in cancer metastasis: A review , 1997, International journal of cancer.

[29]  M. Duffy,et al.  Proteases as prognostic markers in cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.